Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831408) titled 'Study On The Efficacy Of Galactol In Patients With Celiac Disease And Functional Abdominal Disorders' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Condition:
Celiac Disease
Intervention:
Dietary Supplement: Galactol(R)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2026
Target Sample Size: 50
To know more, visit ...